RENAISSANCE TECHNOLOGIES LLC

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in TRDA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,405,760

-$1,144,540 QoQ

Shares Held

191,000

-5.5% QoQ

Ownership

0.491%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 128 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. TRDA ranks #160 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,405,760	191,000	-5.5%	Shares	Sole	2026-08-13
2026-03-31	$2,550,300	202,084	-20.0%	Shares	Sole	2026-05-14
2025-12-31	$2,597,087	252,635	-57.5%	Shares	Sole	2026-02-12
2025-09-30	$3,446,940	594,300	+56.6%	Shares	Sole	2025-11-13
2025-06-30	$2,550,240	379,500	+15.5%	Shares	Sole	2025-08-13
2025-03-31	$2,969,504	328,485	+97.6%	Shares	Sole	2025-05-14
2024-12-31	$2,873,598	166,200	+77.2%	Shares	Sole	2025-02-13
2024-09-30	$1,498,924	93,800	+110.3%	Shares	Sole	2024-11-13
2024-06-30	$635,550	44,600	+278.0%	Shares	Sole	2024-08-09
2022-03-31	$110,802	11,800	-13.1%	Shares	Sole	2022-05-13
2021-12-31	$232,369	13,573	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.